Cargando…

S17.2 Pan-resistant bugs (A. baumanii and P. aeruginosa): Antimicrobial therapy and infection control

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2005
Materias:	Speakers' Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135020/ http://dx.doi.org/10.1016/S0924-8579(05)80084-6

Ejemplares similares

S33.1 Multidrug-resistant Acinetobacter baumanii and Pseudomonas aeruginosa
Publicado: (2005)

Minocycline: The second important antimicrobial in multidrug-resistant Acinetobacter baumanii infections
por: Nair, Abhijit S.
Publicado: (2018)

846. Trends in Acinetobacter baumanii Antibiotic Resistance Rates
por: Caffrey, Aisling, et al.
Publicado: (2020)

1610. Epidemiology and Treatment Heterogeneity in Acinetobacter baumanii Infections
por: Caffrey, Aisling, et al.
Publicado: (2020)

The antibiotic resistance proteome of Acinetobacter baumanii MDR isolate MMC#4
por: Marshall, Dana, et al.
Publicado: (2012)

S31.1 Surveillance: Utilizing statistical process control charts and feedback mechanisms in reducing resistant organisms and healthcare-associated infections
Publicado: (2005)

17.2 EFFICACY OF CANNABIDIOL IN THE TREATMENT OF EARLY PSYCHOSIS.
por: Ranganathan, Mohini, et al.
Publicado: (2018)

Next-gen sequencing of multi-drug resistant Acinetobacter baumanii at Nashville General Hospital at Meharry
por: Dent, Leon, et al.
Publicado: (2011)

S30.2 Risk infections and bioterrorism
Publicado: (2005)

172. Antimicrobial Stewardship in High-risk Pediatric Patients
por: Goldman, Jennifer, et al.
Publicado: (2018)

Intrathecal (intraventricular) polymyxin B in the treatment of patients with meningoencephalitis by Acinetobacter baumanii and Pseudomonas aeruginosa
por: Macedo, SK, et al.
Publicado: (2011)

In vitro activity of imipenem ± aminoglycosides against Pseudomonas aeruginosa and Acinetobacter calcoaceticus / baumanii isolated from patients in ICUs in German hospitals (1999–2002)
por: Mueller, EE, et al.
Publicado: (2003)

1266. Multifaceted Infection Control Strategies to Control Multidrug-Resistant Acinetobacter baumanii in Adult Intensive Care Unit in a Tertiary Hospital in Eastern Region, Saudi Arabia
por: Gammal, Ayman
Publicado: (2018)

Risk factors and outcome associated with coinfection with carbapenem-resistant Klebsiella pneumoniae and carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumanii: a descriptive analysis
por: Sophonsri, Anthony, et al.
Publicado: (2023)

PL1 H. umezawa memorial lecture: Antibiotic usage: Historical perspective and challenges
Publicado: (2005)

Speaker Abstracts
Publicado: (2017)

Speaker 1: Dan Rujescu, Germany
Publicado: (2016)

Speaker 4: Lakshmi Yatham, Canada
Publicado: (2016)

Speaker 2: Jeff Lieberman, USA
Publicado: (2016)

Speaker 2: Celso Arango
Publicado: (2016)

XVIII International Congress of Neuropathology September 15, 2014
Publicado: (2014)

An outbreak of Acinetobacter baumanii in an ICU: effectiveness of an extensive infection control program
por: Bonizzoli, M, et al.
Publicado: (2006)

Use of daptomycin and vancomycin in blood stream infections with PDR Acinetobacter Baumanii
por: Alexandropoulos, P, et al.
Publicado: (2015)

INSP-17. Augmented Drug Delivery for Pediatric Diffuse Midline Glioma using Convection Enhanced Delivery
por: Souweidane, Mark M
Publicado: (2022)

172. Evaluation of Multifaceted Antimicrobial Stewardship Interventions on The Treatment of Asymptomatic Bacteriuria
por: Pham, Tho H, et al.
Publicado: (2020)

Imported PER-1 producing Pseudomonas aeruginosa, PER-1 producing Acinetobacter baumanii and VIM-2-producing Pseudomonas aeruginosa strains in Hungary
por: Szabó, Dora, et al.
Publicado: (2008)

Acynetobacter baumanii extremely resistant outbreak control in ICU: a multidisciplinary approach
por: Muñoz, M, et al.
Publicado: (2015)

Control and Elimination of Extensively Drug-Resistant Acinetobacter baumanii in an Intensive Care Unit
por: Chamieh, Amanda, et al.
Publicado: (2019)

Emergence of tigecycline & colistin resistant Acinetobacter baumanii in patients with complicated urinary tract infections in north India
por: Taneja, Neelam, et al.
Publicado: (2011)

Clinical experiment with the use of colistin for the treatment of multiresistant Acinetobacter baumanii nosocomial infection
por: Safi, L, et al.
Publicado: (2009)

Antimicrobial Resistance and Attributable Burden of Pseudomonas aeruginosa in Hospitalized Patients
por: Zhang, Dongmu, et al.
Publicado: (2017)

Implementation of TasP: challenges and opportunities
por: Lange, Joep
Publicado: (2014)

Evolution of resistance to MAPK-targeted therapies
por: Lo, Roger
Publicado: (2015)

Successful treatment of multicompartmental cerebral ventriculitis caused by Acinetobacter baumanii
por: Mahoney, Dom, et al.
Publicado: (2017)

2830. Clinical Characteristics, Outcomes and Antimicrobial Resistance of Non-aeruginosa Pseudomonas Infection in Adult Cancer Patients
por: Gu, Hyundam, et al.
Publicado: (2023)

P17 Quality assurance in bacterial identification and antimicrobial susceptibility testing results: an essential component of antimicrobial resistance surveillance
por: Githii, Susan, et al.
Publicado: (2022)

First Line Therapy in 2014
por: Nelson, Mark
Publicado: (2014)

Management of an outbreak of multiresistant Acinetobacter baumanii infection in a surgical intensive care unit
por: Lewejohann, J, et al.
Publicado: (2007)

Gene therapy and bone marrow transplantation
por: Van Lunzen, Jan
Publicado: (2014)

Perspective of stem cell research & therapy in diabetes
por: Gupta, Sarita
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_50bipmpabqiu03fc0l18ej4b71